Trial Radar AI

Let's discuss and explore clinical trials with Bristol-Myers Squibb as a lead sponsor or collaborator.

I can help you find nearby clinical trials and understand health conditions and treatments.
16 Clinical Trials
 
Phase
Phase 1
×
 
Type
Drug
×
 
Study Title
Status
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia NCT07423546
Not yet recruiting
A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants NCT07422298
Recruiting
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis NCT07412704
Not yet recruiting
CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis NCT07388277
Not yet recruiting
Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML NCT07355335
Not yet recruiting
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma NCT07333261
Recruiting
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Participants With Relapsed/Refractory Small Cell Lung Cancer NCT07325136
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) NCT07293351
Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) NCT07291076
Recruiting
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants. NCT07283263
Recruiting
A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment NCT07248839
Not yet recruiting
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants NCT07226817
Recruiting
A Study to Assess the Effect of Food on the Drug Levels of Admilparant NCT07225647
Completed
Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants NCT07223671
Completed
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies NCT07223047
Recruiting
A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants NCT07204418
Recruiting